MicroRNA in colorectal cancer: From benchtop to bedside

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 247-253

  Wu, William K K ^a,b   Law, Priscilla T Y ^a   Lee, Chung W ^a,b   Cho, Chi H ^a,b   Fan, Daiming ^c   Wu, Kaichun ^c   Yu, Jun ^a,b   Sung, Joseph J Y ^a,b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; MICRORNA;

APOPTOSIS; BINDING SITE; BIOGENESIS; BLOOD ANALYSIS; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; EARLY DIAGNOSIS; FECES ANALYSIS; GENE EXPRESSION; GENE INTERACTION; GENE SILENCING; GENETIC POLYMORPHISM; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 79952290501     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq243     Document Type: Review

References (112)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Wei,E.K. et al. (2010) Time course of risk factors in cancer etiology and progression. J. Clin. Oncol., 28, 4052-4057.
3. Giovannucci,E. et al. (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 132, 2208-2225.
4. Terzic,J. et al. (2010) Inflammation and colon cancer. Gastroenterology, 138, 2101-2114 e5.
5. Tsoi,K.K. et al. (2009) Cigarette smoking and the risk of colorectal can cer: a meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol., 7, 682-688, e1-e5.
6. Johnson,I.T. et al. (2007) Review article: nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther., 26, 161-181.
7. Jasperson,K.W. et al. (2010) Hereditary and familial colon cancer. Gastroenterology, 138, 2044-2058.
8. Lieberman,D. (2010) Progress and challenges in colorectal cancer screen ing and surveillance. Gastroenterology, 138, 2115-2126.
9. Cunningham,D. et al. (2010) Colorectal cancer. Lancet, 375, 1030-1047.
10. Harris,T.J. et al. (2010) The molecular pathology of cancer. Nat. Rev. Clin. Oncol., 7, 251-265.
11. Yu,W. et al. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature, 451, 202-206.
12. Dong,X.Y. et al. (2009) Implication of snoRNA U50 in human breast cancer. J. Genet. Genomics, 36, 447-454.
13. Dong,X.Y. et al. (2008) SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet., 17, 1031-1042.
14. Carthew,R.W. et al. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell, 136, 642-655.
15. Siomi,H. et al. (2010) Posttranscriptional regulation of microRNA bio genesis in animals. Mol. Cell, 38, 323-332.
16. Eamens,A.L. et al. (2009) The Arabidopsis thaliana double-stranded RNA binding protein DRB1 directs guide strand selection from micro RNA duplexes. RNA, 15, 2219-2235.
17. van den Berg,A. et al. (2008) RISC-target interaction: cleavage and translational suppression. Biochim. Biophys. Acta, 1779, 668-677.
18. Wakiyama,M. et al. (2007) Let-7 microRNA-mediated mRNA deadeny-lation and translational repression in a mammalian cell-free system. Genes Dev., 21, 1857-1862.
19. Didiano,D. et al. (2006) Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol., 13, 849-851.
20. Grimson,A. et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27, 91-105.
21. Kim,M.S. et al. (2010) Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J. Pathol., 221, 139-146.
22. Tsuchiya,N. et al. (2007) SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res., 67, 9568-9576.
23. Cummins,J.M. et al. (2006) The colorectal microRNAome. Proc. Natl Acad. Sci USA, 103, 3687-3692.
24. Akao,Y. et al. (2006) Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29, 903-906.
25. Fang,W.J. et al. (2007) Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. J. Int. Med. Res., 35, 716-723.
26. Earle,J.S. et al. (2010) Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn., 12, 433-440.
27. Arndt,G.M. et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer, 9, 374.
28. Sarver,A.L. et al. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are char acteristic of undifferentiated proliferative states. BMC Cancer, 9, 401.
29. Bandres,E. et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer, 125, 2737-2743.
30. Volinia,S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
31. Motoyama,K. et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol., 34, 1069-1075.
32. Diosdado,B. et al. (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer, 101, 707-714.
33. Wang, Y.X. et al. (2010) Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J. Dig. Dis., 11, 50-54.
34. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
35. Yantiss,R.K. et al. (2009) Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am. J. Surg. Pathol., 33, 572-582.
36. Slaby,O. et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402.
37. Yamamichi,N. et al. (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin. Cancer Res., 15, 4009-4016.
38. Akao,Y. et al. (2010) Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther., 17, 398-408.
39. Kulda,V. et al. (2010) Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet. Cytogenet., 200, 154-160.
40. Huang,Z. et al. (2010) Plasma microRNAs are promising novel bio-markers for early detection of colorectal cancer. Int. J. Cancer, 127, 118-126.
41. Bandres,E. et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer, 5, 29.
42. Wang,C.J. et al. (2009) Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis. Markers, 26, 27-34.
43. Tazawa,H. et al. (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
44. Lodygin,D. et al. (2008) Inactivation of miR-34a by aberrant CpG meth-ylation in multiple types of cancer. Cell Cycle, 7, 2591-2600.
45. Ng,E.K. et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-1381.
46. Strillacci,A. et al. (2009) MiR-101 downregulation is involved in cyclo-oxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res., 315, 1439-1447.
47. Link,A. et al. (2010) Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol. Biomarkers Prev., 19, 1766-1774.
48. Lujambio,A. et al. (2007) Genetic unmasking of an epigenetically si lenced microRNA in human cancer cells. Cancer Res., 67, 1424-1429.
49. Guo,C. et al. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer, 47, 939-946.
50. Li,X.M. et al. Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med. Oncol., doi.10.1007/s12032-010-9637-6, in press.
51. Hu,G. et al. (2010) miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther., 10. 190-197.
52. Nagel,R. et al. (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res., 68, 5795-5802.
53. Balaguer,F. et al. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res., 70, 6609-6618.
54. Michael,M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
55. Akao,Y. et al. (2006) MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep., 16, 845-850.
56. Ng,E.K. et al. (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer, 101, 699-706.
57. Schepeler,T. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
58. Zhang,J. et al. (2010) MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol. Cancer, 9, 211.
59. Valeri,N. et al. (2010) Modulation of mismatch repair and genomic sta bility by miR-155. Proc. Natl Acad. Sci. USA, 107, 6982-6987.
60. Xi,Y. et al. (2006) Prognostic values of microRNAs in colorectal cancer. Biomark. Insights, 2, 113-121.
61. Nakajima,G. et al. (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics, 3, 317-324.
62. Braun,C.J. et al. (2008) p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res., 68, 10094-10104.
63. Liu,L. et al. (2010) microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem. Biophys. Res. Commun., 400, 236-240.
64. Grady,W.M. et al. (2008) Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene, 27, 3880-3888.
65. Calcagno,S.R. et al. (2008) Oncogenic K-ras promotes early carcinogen-esis in the mouse proximal colon. Int. J. Cancer, 122, 2462-2470.
66. Kressner,U. et al. (1998) Ki-ras mutations and prognosis in colorectal cancer. Eur. J. Cancer, 34, 518-521.
67. Brink,M. et al. (2003) K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands cohort study. Carcinogenesis, 24, 703-710.
68. Chen,X. et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 28, 1385-1392.
69. Borralho,P.M. et al. (2009) MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J., 276, 6689-6700.
70. Tsang,W.P. et al. (2009) The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis, 30, 953-959.
71. Rossi,L. et al. (2007) Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol. Res., 56, 248-253.
72. Slansky,J.E. et al. (1996) Transcriptional regulation of the dihydrofolate reductase gene. Bioessays, 18, 55-62.
73. McGuire,J.J. (2003) Anticancer antifolates: current status and future directions. Curr. Pharm. Des., 9, 2593-2613.
74. Mishra,P.J. et al. (2009) MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One, 4, e8445.
75. Song,B. et al. (2008) miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin. Cancer Res., 14, 8080-8086.
76. Boni,V. et al. (2010) miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol. Cancer Ther., 9, 2265-2275.
77. Song,B. et al. (2010) Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol. Cancer, 9, 96.
78. Hermeking,H. (2007) p53 enters the microRNA world. Cancer Cell, 12, 414-418.
79. Tsang,W.P. et al. (2010) Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 31, 350-358.
80. Shi,B. et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J. Biol. Chem., 282, 32582-32590.
81. LaRocca,G. et al. (2009) Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. J. Cell. Physiol. 220, 485-491.
82. Creighton,C.J. et al. (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J. Clin. Oncol., 26, 4078-4085.
83. Gregersen,L.H. et al. (2010) MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One, 5, e8836.
84. Zhang,J. et al. (2011) Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene. Cancer, 117, 86-95.
85. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
86. West,N.J. et al. (2009) Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention. Cancer Epidemiol. Bio-markers Prev., 18, 1680-1687.
87. Qiao,L. et al. (2009) Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist. Updat., 12, 55-64.
88. Yamakuchi,M. et al. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA, 105, 13421-13426.
89. Wang,B.D. et al. (2010) Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. Mol. Cancer, 9, 98.
90. Paris,R. et al. (2008) Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation. Cell Cycle, 7, 2427-2433.
91. Nakano,H. et al. (2010) Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int. J. Cancer, 127, 1072-1080.
92. Kulshreshtha,R. et al. (2007) A microRNA signature of hypoxia. Mol. Cell. Biol., 27, 1859-1867.
93. Ma,Y.L. et al. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. J. Cell. Mol. Med., doi.10.1111/j.1582-4934.2010.01170.x, in press.
94. Schimanski,C.C. et al. (2009) High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J. Gastroenterol., 15, 2089-2096.
95. Hu,M. et al. (2010) MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig. Dis. Sci., 55, 2365-2372.
96. Burk,U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582-589.
97. Yamakuchi,M. et al. (2010) P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl Acad. Sci. USA, 107, 6334-6339.
98. Wellner,U. et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol., 11, 1487-1495.
99. Iliopoulos,D. et al. (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell, 39, 493-506.
100. Ioannidis,J.P. et al. (2010) A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J. Natl Cancer Inst., 102, 846-858.
101. Landi,D. et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579-584.
102. Hunter,M.P. et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 3, e3694.
103. Kosaka,N. et al. (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci., 101, 2087-2092.
104. Schetter,A.J. et al. (2009) Association of inflammation-related and micro RNA gene expression with cancer-specific mortality of colon adenocar-cinoma. Clin. Cancer Res., 15, 5878-5887.
105. Chen,Y. et al. (2010) Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J. Gastrointest. Surg., 14, 1170-1179.
106. Huang,Z.M. et al. (2009) MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer. J. Dig. Dis., 10, 188-194.
107. Diaz,R. et al. (2008) Deregulated expression of miR-106a predicts sur vival in human colon cancer patients. Genes Chromosomes Cancer, 47, 794-802.
108. Graziano,F. et al. (2010) Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Phar-macogenomics J., 10, 458-464.
109. Zhang,W. et al. (2011) A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann. Oncol., 22, 104-109.
110. Boni,V. et al. Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J., doi.10.1038/tpj.2010.58, in press.
111. Krutzfeldt,J. et al. (2005) Silencing of microRNAs in vivo with 'antago-mirs'. Nature, 438, 685-689.
112. Xiang,S. et al. (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol., 24, 697-702.